Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Toronto
Toronto, Ontario, Canada
- Cedars Sinai Medical Center
Los Angeles, California, United States
- University of California Los Angeles
Los Angeles, California, United States
- California Pacific Medical Center
San Francisco, California, United States
- University of California San Francisco
San Francisco, California, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Nih Clinical Center
Bethesda, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Saint Louis University
St Louis, Missouri, United States
- Washington University
St Louis, Missouri, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Baylor University Medical Center
Dallas, Texas, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
- University of Washington Medical Center
Seattle, Washington, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2012
- Primary completion
- 14 Feb 2017
- Completion
- 14 Feb 2017
- Last update posted
- 26 May 2022
- Registered enrollment
- 28
- Registry id
- NCT01369199
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.